COMMUNIQUÉS West-GlobeNewswire
-
Financière de Tubize - Approbation du dividende
27/04/2024 - 08:00 -
Financière de Tubize - Dividend approval
27/04/2024 - 08:00 -
Rakovina Therapeutics Inc. Announces 2023 Financial Results and Provides Corporate Update
27/04/2024 - 02:38 -
BrightSpring Health Services, Inc. Welcomes Timothy A. Wicks to Board of Directors
26/04/2024 - 23:09 -
STRATA Skin Sciences Announces 1-for-10 Reverse Stock Split
26/04/2024 - 23:20 -
Appili Therapeutics Announces Additional Bridge Loan from Bloom Burton & Co.
27/04/2024 - 01:03 -
Sino Biological Finalizes the Acquisition of SignalChem Biotech, Strengthening Global Presence and Expanding Product Portfolio
26/04/2024 - 20:25 -
Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
26/04/2024 - 22:05 -
Cronos Group Inc. to Hold Virtual 2024 Annual Meeting of Shareholders
26/04/2024 - 22:45 -
Lyra Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
26/04/2024 - 22:51 -
BioSenic publie sur son site web le plan de restructuration soumis au tribunal des entreprises de Nivelles
26/04/2024 - 17:30 -
BioSenic publishes on its website the restructuring plan submitted to the Enterprise Court of Nivelles
26/04/2024 - 17:30 -
Eurobio Scientific : Rapport Financier Annuel 2023
26/04/2024 - 17:40 -
Eurobio Scientific : mise à disposition du rapport financier annuel 2023
26/04/2024 - 17:45 -
SAFE - Report de publication des résultats annuels et du rapport financier annuel 2023
26/04/2024 - 17:45 -
CARBIOS celebrates the groundbreaking of its PET biorecycling plant, a world first, with its partners
26/04/2024 - 19:17 -
Ibogaine By David Dardashti Acknowledges Importance of Body Image in Addiction and Mental Health Recovery
26/04/2024 - 19:53 -
CG Oncology to Host Virtual Investor Event on Friday, May 3, 2024
26/04/2024 - 14:00 -
Cidara Therapeutics Announces Presentations Highlighting Phase 1 and Phase 2a Clinical Data on CD388 at ESCMID 2024
26/04/2024 - 14:00
Pages